Assyro AI

Orange Book product · Brand (NDA)

VALCHLOR

MECHLORETHAMINE HYDROCHLORIDE

Brand (NDA)NDA 202317RX HELSINN

At a glance

Aug 23, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

6

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 23, 2013

    13 yr ago

  2. Patent 7838564 expires

    Listed drug product patent expiration.

    Mar 07, 2026

    3 mo ago

  3. Patent 8450375 expires

    Listed drug product patent expiration.

    Mar 07, 2026

    3 mo ago

  4. Patent 8501818 expires

    Listed drug product patent expiration.

    Mar 07, 2026

    3 mo ago

  5. Patent 8501819 expires

    Listed method-of-use patent (U-1427) expiration.

    Mar 07, 2026

    3 mo ago

  6. Patent 9382191 expires

    Listed drug product patent expiration.

    Mar 07, 2026

    3 mo ago

  7. Today

  8. Patent 7872050 expires

    Listed method-of-use patent (U-1427) expiration.

    Jul 08, 2029

    in 3 yr 1 mo

Pharmaceutical detail

Active ingredient

MECHLORETHAMINE HYDROCHLORIDE

Strength

EQ 0.016% BASE

Dosage form

GEL

Route

TOPICAL

TE code

Not listed

Application

NDA 202317

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
7838564Mar 07, 20263 mo ago
Product
8450375Mar 07, 20263 mo ago
Product
8501818Mar 07, 20263 mo ago
Product
8501819Mar 07, 20263 mo ago
U-1427
9382191Mar 07, 20263 mo ago
Product
7872050Jul 08, 2029in 3 yr 1 mo
U-1427
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.